Premium
Cancer immunotherapy trial design with random delayed treatment effect and cure rate
Author(s) -
Wu Jianrong,
Wei Jing
Publication year - 2021
Publication title -
statistics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.996
H-Index - 183
eISSN - 1097-0258
pISSN - 0277-6715
DOI - 10.1002/sim.9258
Subject(s) - immunotherapy , sample size determination , medicine , cancer immunotherapy , cancer , clinical trial , cure rate , oncology , randomized controlled trial , statistics , hazard ratio , mathematics , confidence interval
Immunotherapies are increasingly used for treating patients with advanced‐stage cancers. However, cancer immunotherapy trials often present delayed treatment effects and long‐term survivors which result nonproportional hazard models and challenge the immunotherapy trial designs. In this article, we proposed a general random delayed cure rate model for designing cancer immunotherapy trials. A sample size formula is derived for a weighted log‐rank test. The accuracy of sample size estimation is assessed and compared with the existing methods via simulation studies. The sensitivities for misspecifying the random delay time are also studied through simulations.